Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Chinese Patent Office
Chubb
Harvard Business School
Baxter
McKesson
Cantor Fitzgerald
Daiichi Sankyo
Accenture
Deloitte

Generated: January 16, 2018

DrugPatentWatch Database Preview

Dexrazoxane hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for dexrazoxane hydrochloride and what is the scope of dexrazoxane hydrochloride freedom to operate?

Dexrazoxane hydrochloride
is the generic ingredient in three branded drugs marketed by Gland Pharma Ltd, Mylan Institutional, West-ward Pharms Int, Clinigen Hlthcare, and Pharmacia And Upjohn, and is included in five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Dexrazoxane hydrochloride has twenty-two patent family members in sixteen countries.

There are six drug master file entries for dexrazoxane hydrochloride. Seven suppliers are listed for this compound.
Summary for dexrazoxane hydrochloride
Pharmacology for dexrazoxane hydrochloride
Medical Subject Heading (MeSH) Categories for dexrazoxane hydrochloride

US Patents and Regulatory Information for dexrazoxane hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-001 May 26, 1995 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Institutional DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 200752-002 Oct 19, 2011 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 076068-002 Sep 28, 2004 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Institutional DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 200752-001 Oct 19, 2011 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Clinigen Hlthcare TOTECT dexrazoxane hydrochloride INJECTABLE;INJECTION 022025-001 Sep 6, 2007 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 076068-001 Sep 28, 2004 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gland Pharma Ltd DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 207321-001 Nov 28, 2016 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for dexrazoxane hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-001 May 26, 1995 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-001 May 26, 1995 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-001 May 26, 1995 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for dexrazoxane hydrochloride

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Chinese Patent Office
Fuji
Novartis
UBS
US Department of Justice
Healthtrust
Baxter
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot